Companies: 10,795·Total market cap: $144.5T
Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc.

LFCRNASDAQHealthcare● Active
$5.57
$-0.06(-1.07%)
Market Cap$208927397
P/E Ratio
52W High$8.98
52W Low$3.63
Overview

Lifecore Biomedical, Inc. (LFCR) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LFCR · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.03lfcr eps ttm · lfcr earnings per shareEarnings history
PE Ratio (TTM)lfcr pe ratio ttm · lfcr price to earningsPE Ratio deep dive
Revenue (TTM)$135.2Mlfcr revenue ttm · lfcr annual revenueFull revenue history
Dividend YieldNo Dividenddoes lfcr pay dividends · lfcr dividend yieldDividend history
Shares Outstanding34.8Mlfcr shares outstanding · lfcr floatShares outstanding history
Next EarningsJul 31, 2026Est.lfcr earnings date · lfcr next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$128.9M▲ +0.47% YoY
202320242025
lifecore biomedical, inc. revenue · lfcr revenue 2025
FY 2025Net Income-$38.7M▼ 422.29% YoY
202320242025
lifecore biomedical, inc. net income · lfcr profit 2025
FY 2025EPS$-1.27▼ 425.64% YoY
202320242025
lfcr eps · lifecore biomedical, inc. earnings per share 2025
TTM:Revenue: $135.2MNet Income: -$34.1MEPS: $-1.03View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy7 analystsis lfcr a buy · lfcr analyst rating
Strong Buy
0
Buy
5
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$6.00Low
$5.57Current
$6.00Avg Target7.72% upside
$6.00High
lfcr price target · lfcr 12 month forecast

Total: 7 · Buy rate: 71.4%

The LFCR analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +7.72% upside from the current price of $5.57.

Stock Performance

Full History
1D-1.42%
1W+1.65%
1M+15.87%
3M-20.26%
YTD-32.15%
1Y-18.14%
5Y-56.33%

About Lifecore Biomedical, Inc.

CEOPaul Josephs
IPO DateFeb 15, 1996
Employees524
CountryUS

Lifecore Biomedical, Inc. (LFCR) operates as a multifaceted contract development and manufacturing organization (CDMO) with a global presence, conducting business through its various subsidiaries. The…

what is lifecore biomedical, inc. · lfcr stock overview · lifecore biomedical, inc. company profile · who is lifecore biomedical, inc. ceo · lfcr NASDAQ · lifecore biomedical, inc. headquarters · lifecore biomedical, inc. business segments

About Stock Overview & Key Data

Lifecore Biomedical, Inc. (LFCR) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Feb 15, 1996. As of the latest trading session, LFCR stock price is $5.57, with a market capitalization of $208.9M. The stock has returned -18.14% over the past 12 months and -32.15% year-to-date.

According to 7 Wall Street analysts, the consensus rating for Lifecore Biomedical, Inc. stock is Buy, with an average 12-month price target of $6.00. In fiscal year 2025, Lifecore Biomedical, Inc. reported revenue of $128.9M and net income of -$38.7M. For detailed data — including Lifecore Biomedical, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Lifecore Biomedical, Inc. (LFCR) stock price is $5.57. The stock is traded on NASDAQ under the ticker symbol LFCR. The 52-week range is $3.63 – $8.98.

LFCR stock priceLFCR quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice